Companies: 10,795·Total market cap: $144.5T
Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

TMONYSEHealthcare● Active
$472.86
+$0.06(+0.01%)
Market Cap$175.7B
P/E Ratio
52W High$643.99
52W Low$385.46

Thermo Fisher Scientific Inc.(TMO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · TMO · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$44.56B$42.88B$42.86B$44.91B$39.21B
Cost of Revenue$27.78B$25.15B$25.66B$25.90B$19.58B
Gross Profit$16.78B$17.73B$17.19B$19.01B$19.63B
Gross Margin %(computed)37.66%41.34%40.12%42.33%50.07%
Operating Expenses
R&D Expenses$1.40B$1.39B$1.34B$1.47B$1.41B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$8.67B$10.07B$9.75B$10.49B$9.32B
Operating Income$8.11B$7.66B$7.45B$8.53B$10.32B
Operating Margin %(computed)18.20%17.87%17.37%18.98%26.31%
Interest Income$0.99B$1.08B$0.88B$0.27B$0.04B
Interest Expense$1.42B$1.65B$1.49B$0.73B$0.54B
Income Before Tax$7.27B$7.00B$6.24B$7.66B$8.84B
Income Tax Expense$0.55B$0.66B$0.28B$0.70B$1.11B
Net Income$6.74B$6.33B$6.00B$6.95B$7.72B
Net Margin %(computed)15.12%14.77%13.99%15.47%19.70%
Per Share & EBITDA
EPS (Basic)$17.77$16.58$15.53$17.73$19.61
Wtd Avg Shares0.38B0.38B0.39B0.39B0.39B
EBITDA$11.47B$11.80B$11.20B$11.94B$11.97B
EBITDA Margin %(computed)25.73%27.52%26.12%26.59%30.52%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Thermo Fisher Scientific Inc.

关于Thermo Fisher Scientific Inc.(TMO)损益表

Thermo Fisher Scientific Inc.(TMO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,TMO实现营收$44.56B,毛利润$16.78B(毛利率37.66%),净利润$6.74B(净利率15.12%)。

常见问题

TMO · 4 问

Thermo Fisher Scientific Inc.(TMO)2025财年营收为$44.56B,同比up3.9%。

TMO revenueTMO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08